The Effects of COVID-19 on the Placenta During Pregnancy.
Rad, HS
Röhl, J
Stylianou, N
Allenby, MC
Bazaz, SR
Warkiani, ME
Guimaraes, FSF
Clifton, VL
Kulasinghe, A
- Publisher:
- Frontiers Media SA
- Publication Type:
- Journal Article
- Citation:
- Front Immunol, 2021, 12, pp. 743022
- Issue Date:
- 2021
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Rad, HS | |
dc.contributor.author | Röhl, J | |
dc.contributor.author | Stylianou, N | |
dc.contributor.author | Allenby, MC | |
dc.contributor.author | Bazaz, SR | |
dc.contributor.author | Warkiani, ME | |
dc.contributor.author | Guimaraes, FSF | |
dc.contributor.author | Clifton, VL | |
dc.contributor.author | Kulasinghe, A | |
dc.date.accessioned | 2022-05-14T04:16:35Z | |
dc.date.available | 2021-08-26 | |
dc.date.available | 2022-05-14T04:16:35Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Front Immunol, 2021, 12, pp. 743022 | |
dc.identifier.issn | 1664-3224 | |
dc.identifier.issn | 1664-3224 | |
dc.identifier.uri | http://hdl.handle.net/10453/157345 | |
dc.description.abstract | Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. The virus primarily affects the lungs where it induces respiratory distress syndrome ranging from mild to acute, however, there is a growing body of evidence supporting its negative effects on other system organs that also carry the ACE2 receptor, such as the placenta. The majority of newborns delivered from SARS-CoV-2 positive mothers test negative following delivery, suggesting that there are protective mechanisms within the placenta. There appears to be a higher incidence of pregnancy-related complications in SARS-CoV-2 positive mothers, such as miscarriage, restricted fetal growth, or still-birth. In this review, we discuss the pathobiology of COVID-19 maternal infection and the potential adverse effects associated with viral infection, and the possibility of transplacental transmission. | |
dc.format | Electronic-eCollection | |
dc.language | eng | |
dc.publisher | Frontiers Media SA | |
dc.relation.ispartof | Front Immunol | |
dc.relation.isbasedon | 10.3389/fimmu.2021.743022 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | 1107 Immunology, 1108 Medical Microbiology | |
dc.subject.mesh | Abortion, Spontaneous | |
dc.subject.mesh | Angiotensin-Converting Enzyme 2 | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Female | |
dc.subject.mesh | Fetal Growth Retardation | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Maternal-Fetal Exchange | |
dc.subject.mesh | Placenta | |
dc.subject.mesh | Pregnancy | |
dc.subject.mesh | Pregnancy Complications, Infectious | |
dc.subject.mesh | SARS-CoV-2 | |
dc.subject.mesh | Serine Endopeptidases | |
dc.subject.mesh | Stillbirth | |
dc.subject.mesh | Placenta | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Pregnancy Complications, Infectious | |
dc.subject.mesh | Abortion, Spontaneous | |
dc.subject.mesh | Fetal Growth Retardation | |
dc.subject.mesh | Serine Endopeptidases | |
dc.subject.mesh | Pregnancy | |
dc.subject.mesh | Maternal-Fetal Exchange | |
dc.subject.mesh | Female | |
dc.subject.mesh | Stillbirth | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Angiotensin-Converting Enzyme 2 | |
dc.subject.mesh | SARS-CoV-2 | |
dc.title | The Effects of COVID-19 on the Placenta During Pregnancy. | |
dc.type | Journal Article | |
utslib.citation.volume | 12 | |
utslib.location.activity | Switzerland | |
utslib.for | 1107 Immunology | |
utslib.for | 1108 Medical Microbiology | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Engineering and Information Technology | |
pubs.organisational-group | /University of Technology Sydney/Strength - CHT - Health Technologies | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Engineering and Information Technology/School of Biomedical Engineering | |
pubs.organisational-group | /University of Technology Sydney/Strength - IBMD - Initiative for Biomedical Devices | |
pubs.organisational-group | /University of Technology Sydney/Centre for Health Technologies (CHT) | |
utslib.copyright.status | open_access | * |
dc.date.updated | 2022-05-14T04:16:32Z | |
pubs.publication-status | Published online | |
pubs.volume | 12 |
Abstract:
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. The virus primarily affects the lungs where it induces respiratory distress syndrome ranging from mild to acute, however, there is a growing body of evidence supporting its negative effects on other system organs that also carry the ACE2 receptor, such as the placenta. The majority of newborns delivered from SARS-CoV-2 positive mothers test negative following delivery, suggesting that there are protective mechanisms within the placenta. There appears to be a higher incidence of pregnancy-related complications in SARS-CoV-2 positive mothers, such as miscarriage, restricted fetal growth, or still-birth. In this review, we discuss the pathobiology of COVID-19 maternal infection and the potential adverse effects associated with viral infection, and the possibility of transplacental transmission.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph